Masuoka K. Lorianne - 15 Jun 2021 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Lorianne Masuoka
Issuer symbol
N/A
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
16 Jun 2021, 16:04:18 UTC
Next filing
14 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Award $0 +2,000 $0.000000 2,000 15 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date.